Royalty Pharma Operating Metrics

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Portfolio Receips	2.92B	2.80B	2.80B	2.70B	2.63B	3.05B	3.38B	3.34B
Portfolio Receips Growth	10.97%	-8.11%	-17.21%	-19.13%	-20.54%	9.30%	48.85%	47.71%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.